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ABSTRACT. Neural tube defects (NTD) are among the most common 
congenital abnormalities, with an incidence of 3 per 1000 live births 
in Turkey. In a study of major congenital abnormalities in the city 
of Denizli, Turkey, abnormalities of the central nervous system are 
particularly common (31.1%). The objective of this study was to 
develop a registry of cases with NTDs in Denizli. Cases that had been 
diagnosed with NTD between January 2004 and September 2010 in 
State Hospitals of Central Denizli were retrospectively examined. The 
diagnoses were established based on the ICD-10 criteria. A total of 250 
subjects with NTD were identified, including 123 (49.2%) females 
and 127 (50.8%) males with a mean age of 13.72 ± 15.62 years (age 
range 1-81 years). Interestingly, spina bifida constituted a significant 
percentage of the cases (149 cases; 59.6%). In addition, 10 (4.0%) 
cases had hydrocephalus plus spina bifida. The second most common 
diagnosis was microcephaly, which included 70 cases (28.0%). 
Encephalocele was observed in only 2 cases (0.8%). Development of 
NTD is influenced by nutrition, socioeconomic factors, and the use 
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of folic acid during the peri-conceptional period. Studies examining 
the effect of these factors on NTD in Turkey and a review of primary 
prevention measures are necessary.
Key words: Folic acid; Neural tube defect; Registry; Spina bifida; 
Turkey
INTRODUCTION
Neural tube defects (NTD) are among the most common congenital abnormalities and 
are a major cause of infantile and childhood deaths (Tolmie, 1996; Cengiz et al., 2004; Medvec-
zky and Puho, 2004). The most common forms of NTD include anencephaly and spina bifida. 
Anencephaly is a congenital defect resulting from impaired closure of the top of the neural tube; 
these infants die shortly after birth (Tinkle and Sterling, 1997; Reeder et al., 1997).
Loss of the Sox2 gene was the most frequently observed genetic abnormality in sub-
jects with NTDs (16%). Although Nanog3 upregulation is observed in 48%, Oct4 and Sox2 in 
40% of the patients, the differences were not significant, only null mutation was significantly 
correlated with NTD (Saxena et al., 2013). The most common maternal risk factors associated 
with NTDs in infants include folic acid deficiency, overweight, diabetes, drugs, consanguinity, 
and single-nucleotide polymorphisms (Kondo et al., 2009; Herrmann and Obeid, 2011; Carter 
et al., 2011). The prevalence of NTDs at birth varies significantly by national geographical 
strata, ethnicity, and racial groups. Worldwide, 250,000 NTDs are diagnosed annually during 
pregnancy (Wald et al., 2001). The frequency of NTD has been reported to be 0.1% in Europe 
and 0.2% in the USA (American Academy of Pediatrics, 1993; Friel et al., 1995). The incidence 
of spina bifida and anencephaly in 10,000 live births is 0.9 in Canada, 7.7 in the United Arab 
Emirates, 0.7 in France, and 11.7 in South America (Tolmie, 1996). This rate is 1 in 100 in some 
parts of China and 1 or less in 5000 births in Scandinavian countries (Botto and Yang, 2000).
NTDs are among the most severe congenital abnormalities in Turkey; epidemiological 
findings indicate that prevalence rates vary with regional and demographic features. However, 
this information is currently not available in the Turkish medical registry system (Tunçbilek, 
2004); according to data obtained from various cities of Turkey (Akar et al., 1989; Mocan 
et al., 1992; Posaci et al., 1992; Güvenc et al., 1993; Himmetoğlu et al., 1996; Tunçbilek 
et al., 1999), the prevalence of NTD ranges from 3-5.8 per 1000 births (Tunçbilek, 2004). 
Rates as high as 8.9 in Izmir and 20.0 per 1000 births in Mustafa Kemal Pasa of Bursa have 
been recorded following the Chernobyl disaster (Hoffmann, 2001). A university clinical study 
demonstrated that the frequency of NTD is highest in Northern and Eastern Anatolia, with an 
incidence of 4.32 and 4.54 per 1000 live births, and is lowest in Western Anatolia, with an inci-
dence of 2.17 per 1000 live births. This rate was 9.1 per 1000 live births in uneducated mothers 
who were evaluated based on maternal education level (Tunçbilek, 2004). A study by Bati et 
al. (2007) revealed that the incidence of NTD was 1.5 in 1000 births in all hospitals in Izmir. 
In Afyonkarahisar, the incidence of NTD was found to be 3.58 in 1000 live births (Onrat et al., 
2009). Abnormalities of the central nervous system rank highest among studies investigating 
the registries of major congenital abnormalities in Denizli (31.1%) (Tomatir et al., 2009). The 
objective of this study was to identify NTD cases in registries of Denizli, highlight the disease 
incidence, and suggest appropriate measure that may be taken in Turkey. 
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MATERIAL AND METHODS
This descriptive and retrospective study on NTD survival was performed in two hos-
pitals (Servergazi and Denizli State Hospitals) in Denizli, Turkey between January 2004 and 
September 2010. NTDs were defined according to the ICD-10 criteria. Data were analyzed 
using the Statistical Package for the Social Sciences, v. 10 (SPSS Inc., Chicago, IL, USA). 
Descriptive statistics are presented as frequencies and percentages.
RESULTS
Totally 250 NTD cases were identified in the registries of Denizli State Hospital in 
52.3% and Servergazi State Hospital in 47.7% from September 1-30, 2010. There were 123 fe-
males (49.2%) and 127 males (50.8%), with a mean age of 13.72 ± 15.62 years (range, 1-81). 
A total of 149 spina bifida cases (59.6%), and 10 cases with spina bifida plus hydrocephalus 
(4.0%) were identified. Seventy cases had been diagnosed with microcephaly (28.0%) and 2 
with encephalocele (0.8%). Other less frequent findings are presented in Table 1. Approxi-
mately half of the NTDs (44.8%) were under the age of 5 years (Table 2).
Age (years) N %
0-5 112 44.8
6-10   23   9.2
11-15   27 10.8
16-20   24   9.6
21-25   17   6.8
26-30   10   4.0
31-35   11   4.4
36-40     8   3.2
41-45     5   2.0
46-50     6   2.4
51-55     1   0.4
56-60     0   0.0
61-65     2   0.8
66-70     3   1.2
>71     1   0.4
Total 250 100
Table 2. Distribution of neural tube defects (NTDs) by age.
NTDs ICD-10 code N   (%)            Gender
                            Female                           Male
    N   (%) N   (%)
Spina bifida Q05 149   (59.6)   67 (54.5)   82 (64.6)
Microcephaly Q02   70   (28.0)   37 (30.1)   33 (26.0)
Spina bifida and hydrocephaly Q05.2   10     (4.0)     8   (3.5)     2   (1.6)
NTD and other anomalies Q06   11     (4.4)     7   (2.7)     4   (3.1)
Other cerebral anomalies Q04     7     (2.8)     4   (1.6)     3   (2.4)
Encephalocele Q01     2     (0.8) -   (0.0)     2   (1.6)
Malformation of aquaductus silvii Q03.0     1     (0.4) -   (0.0)     1   (0.8)
Total  250 (100.0) 123 (49.2) 127 (50.8)
NTDs = neural tube defects; N = number of cases.
Table 1. Distribution of NTD types by gender.
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DISCUSSION
The European Registration of Congenital Abnormalities and Twins (EUROCAT) re-
ported a significantly higher prevalence of NTDs in most European countries compared to 
countries with micronutrient fortification programs (www.eurocat-network.eu). The mean rate 
of NTD in the EUROCAT was 7.88 per 10,000 births from 2004-2008 (Herrmann and Obeid, 
2011; Khoshnood et al., 2011). The incidence of NTD in Turkey is even greater than that in 
Europe and the USA. Also Tunçbilek et al. (1999) reported that the rate of NTD is 1.20 in Tur-
key. In another study in Turkey, 100 (1.2%) of 8408 infants admitted to the neonatal intensive 
care unit were diagnosed with NTD during the study period. Prenatal diagnosis was made in 
72% of cases, but the parents chose to continue the pregnancy. The most frequent type and site 
of NTD was meningomyelocele (82%) of the lumbosacral region (36%) (Aygün et al., 2013).
In this study, spina bifida was the most frequently observed condition (149 cases; 
59.6%), followed by microcephaly (70 cases; 2.0%). In addition, 10 cases (4.0%) were deter-
mined to have hydrocephaly plus spina bifida. Encephalocele was found in only 2 cases (0.8%). 
In a similar study, Rankin et al. (2000) reported a total of 984 NTD cases, including 403 (43.1%) 
cases of anencephaly, 472 (50.5%) spina bifida, and 59 (6.3%) encephalocele. Zlotogora et al. 
(2002) reported 401 NTD cases (167 cases of anencephaly, 167 cases of spina bifida, 48 cases of 
encephalocele, and 19 cases with other malformations) between the years 1999-2000. Twenty-
three pregnancies were affected by anencephaly, 3 with spina bifida, and 1 with encephalocele. 
The anencephaly rate was 8.4 per 10,000 live births [95% confidence interval (CI) = 4.5-12.0], 
compared with a national estimate of 2.1 per 10,000 live births (CI = 1.9-2.2). In contrast, the 
rate of spina bifida was 1.3 per 10,000 live births (CI = 0.3-3.8), compared with 3.5 per 10,000 
live births nationally (CI = 3.3-3.7) (Centers for Disease Control and Prevention, 2013).
Environmental factors are well known to affect the etiology of neural tube defects 
(Rankin et al., 2000). Women who smoked during pregnancy showed a mildly elevated risk 
[odds ratio (OR) =1.03, 95%CI = 0.80-1.33] of having infants with NTDs (Wang et al., 2014). 
The geographical distribution of NTDs in Turkey indicates a relationship between the devel-
opment of NTDs and socioeconomic and environmental factors. Although some polymor-
phisms leading to genetic effects have been demonstrated in studies worldwide (Botto and 
Yang, 2000; Pangilinan et al., 2010; Carter et al., 2011), the specific genes and genetic factors 
involved have yet to be determined. A 677C→T mutation in the methylenetetrahydrofolate 
reductase gene, which is thought to cause NTDs, is not a risk factor in the Turkish population 
(Boduroğlu et al., 1999). The large differences observed in the incidence of NTD according 
to maternal education, age, and socio-economic factors have suggested that in addition to 
potential genetic factors, various environmental factors, such as nutrition, play major roles in 
disease incidence. Studies examining the causative role of folic acid deficiency in NTD in dif-
ferent countries have demonstrated that improvement in maternal folic acid levels prevented 
NTD recurrence and decreased NTD incidence (Tunçbilek, 2004).
Folates and vitamin B12 play fundamental roles in central nervous system function at 
all ages, particularly in purine, thymidine, nucleotide, and DNA synthesis, as well as genomic 
and nongenomic methylation, and therefore in tissue growth, differentiation, and repair (Reyn-
olds, 2014). The mandatory fortification of staple foods rich in folic acid to prevent NTDs 
began in the USA in 1998. Since then, more than 50 countries worldwide have implemented 
similar programs (Herrmann and Obeid, 2011). Peri-conceptional use of folic acid in women 
of child-bearing potential has significantly decreased the incidence of NTD in England and 
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Ireland (Rankin et al., 2000). A study performed in Ontario, Canada found that the prevalence 
of NTDs decreased from 1.13 to 0.58 per 1000 births in women following fortification with 
food with an additional 0.2 mg folic acid content (Ray et al., 2002). A rate of 54% was reported 
in another study performed in a different region of Canada (Nova Scotia) (Persad et al., 2002). 
Another study performed in Canada found that fortification of foods led to a 100-mg increase 
in daily folic acid intake in adults. However, the 400 mg daily folic acid requirement is not 
being met (French et al., 2003). Replacement with folic acid tablets in addition to fortification 
of foods appears to be the most effective method for meeting this need. Various studies per-
formed in these countries demonstrated that the rate of use of folic acid tablets remains at 30% 
because of factors such as lack of information, cost, and dislike of the tablet (Tunçbilek, 2004). 
Most infants with NTDs die in the first year after birth. In this study, approximately 
half of the NTDs were less than 5 years old. Aygün et al. (2013) reported that in 80% of the 
babies, the NTD sac was closed within the first 72 h of life. The most frequently observed 
postoperative complications included wound infection and septicemia. The mortality rate of 
infants with NTD during the follow-up period was 7%, and all deaths occurred in the first year 
of life. Sixty-two percent of the patients were found to have neurological deficits upon follow-
up. Patients were re-hospitalized during the follow-up period an average of 2.9 times.
These results indicate the important role of health care providers in informing the 
public and patients. In addition, the role of mass media should not be disregarded and should 
be used effectively.
Strengths and limitations
Data were obtained from 3 different registry systems. The data was entered into 
the system by specialist physicians. Only NTD cases that had survived after birth could be 
reached for participation in this survey. No information regarding concomitant syndromes 
was provided. Information regarding the mother or family could not be obtained. Thus, these 
data do not include infants that have not yet been born or terminated pregnancies. Therefore, 
prevalence has not been provided in this study since it does not conform to other national 
data. Better registry systems for compiling national data should be developed. Information 
regarding prenatal screening, prenatal diagnosis, results of pregnancy screening, and family 
considerations should be included in the registry forms.
CONCLUSIONS
New education methods should be developed in addition to fortification of food rich in 
folic acid and supplementation with folic acid tablets to decrease the high incidence of NTDs. 
New strategies should be determined by the Ministry of Health as well as by universities, non-
governmental organizations, and related institutions. Further studies should be performed to 
determine the differences in the incidence and distribution of NTD as well as etiological and 
genetic factors in Turkey. In addition, a better national registry system should be developed.
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